AbbVie To Acquire ADC Bio/Pharm Company ImmunoGen for $10.1 Bn 
By

By
AbbVie has agreed to acquire ImmunoGen, a Waltham, Massachusetts-based bio/pharmaceutical company developing antibody drug conjugates (ADCs), for approximately $10.1 billion.  ImmunoGen’s commercial product is Elahere (mirvetuximab soravtansine-gynx), an ADC for…

Lilly To Invest $2.5 Bn for New Injectable Mfg Site 
By

By
Eli Lilly and Company has announced plans to construct a new $2.5-billion injectable manufacturing site in Alzey, Rhineland-Palatinate, Germany.   This new facility will further expand the company’s global parenteral (injectable)…

Novo Nordisk To Invest $2.3 Bn To Expand Aseptic, Finished Product Mfg 
By

By
Novo Nordisk is investing DKK 16 billion ($2.3 billion) over the next four years to expand its production site in Chartres, France, for its current and future product portfolio within…

Supplier News: Euroapi, Pharmathen, MilliporeSigma & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Euroapi, Pharmathen, MilliporeSigma, Hovione, Batavia Biosciences, Hermes Pharma and Sohm.   Chemicals/Chemical API Manufacturing * Euroapi Acquires Oligo CDMO BianoGMPBiologics Manufacturing * Batavia Biosciences Opens…

Global Briefs: Amgen, Merck & Co., BMS, Astellas & More 
By

By
A roundup of news from Amgen/Amazon, Merck & Co./Caraway Therapeutics, Bristol Myers Squibb/Avidity Biosciences, and Astellas/Propella Therapeutics. Highlights below.   Manufacturing News * Amgen, Amazon Partner for AI in Mfg Partnering * BMS, Avidity…

Novo Nordisk To Invest $6.1 Bn In API Mfg Facility 
By

By
Novo Nordisk has announced an investment of more than DNK 42 billion ($6.1 billion) starting in 2023 to expand existing manufacturing facilities in Kalundborg, Denmark, for the company’s current and future…

Ajinomoto To Acquire Forge Biologics for $554 M 
By

By
Ajinomoto Co. has agreed to acquire Forge Biologics, an Ohio-based gene-therapy CDMO, for approximately $554 million.  The acquisition will be completed through Ajinomoto’s subsidiary, Ajinomoto North America Holdings, (ANH), and ANH…

Supplier News: Vetter & Adragos Pharma 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Vetter and Adragos Pharma.   Formulation Development/Drug Product Manufacturing * Vetter’s European Clinical Injectable Site Receives Permanent Manufacturer’s Authorization * Adragos Pharma Acquires Sterile Mfg…

Partnering News: Bayer, Novartis, Gilead & More 
By

By
A roundup of bio/pharmaceutical partnering news from Bayer/Recursion Pharma, Novartis/Legend Biotech and Gilead/Arcellx.  * Bayer, Recursion Pharma in $1.5-Bn Oncology Drug Research Pact* Novartis, Legend Biotech In $1.1-Bn CAR-T Licensing…

Supplier News: Olon, BioCina, Noramco & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Olon, BioCina, Noramco and Cambrex.   Chemicals/Chemical API Manufacturing * Olon To Invest $10.7 M to Expand India API Mfg Site  Biologics Manufacturing * BioCina,…